AI fast-tracks human longevity extension - Deep Longevity

Deep Longevity, which specialises in the development and the application of next-generation AI for aging and longevity research, has announced the publication of an article in Nature Aging titled Artificial Intelligence in Longevity Medicine, written by Alex Zhavoronkov, Evelyne Yehudit Bischof and Kai-Fu Lee. Longevity.Technology: Longevity and AI are deeply enmeshed; from accelerating innovation and technology transfer, to developing personalised health therapies, the presence of AI is a key factor in extending lifespan and healthspan and ensuring maximum wellness. Next-generation AI could not only improve longevity investigative strategies and research, but push them in entirely new directions – vive la révolution! Hong Kong-based Deep Longevity was spun out of Insilico Medicine and quickly acquired by Regent Pacific. It develops explainable AI systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological and psychological levels, as well as developing systems for the emerging field of longevity medicine. Creators of deep aging clocks that leverage data from multiple biomarkers, Deep Longevity, through a research partnership with Human Longevity, Inc, provides various aging clocks to physicians and researchers.